A detailed history of Wealth Bridge Investment Counsel Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Bridge Investment Counsel Inc. holds 36,746 shares of ABBV stock, worth $6.61 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
36,746
Previous 36,551 0.53%
Holding current value
$6.61 Million
Previous $6.27 Million 15.76%
% of portfolio
2.58%
Previous 2.4%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $31,948 - $38,869
195 Added 0.53%
36,746 $7.26 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $123,832 - $144,608
800 Added 2.24%
36,551 $6.27 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $58,334 - $66,466
-365 Reduced 1.01%
35,751 $6.51 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $82,560 - $92,982
600 Added 1.69%
36,116 $5.6 Million
Q3 2023

Oct 17, 2023

SELL
$133.59 - $154.65 $130,116 - $150,629
-974 Reduced 2.67%
35,516 $5.29 Million
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $179,418 - $223,274
1,354 Added 3.85%
36,490 $4.92 Million
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $114,531 - $131,899
792 Added 2.31%
35,136 $5.6 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $164,312 - $197,053
1,188 Added 3.58%
34,344 $5.55 Million
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $388,537 - $445,627
2,895 Added 9.57%
33,156 $4.45 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $137,620 - $174,960
1,000 Added 3.42%
30,261 $4.64 Million
Q1 2022

Apr 05, 2022

BUY
$131.98 - $163.75 $51,472 - $63,862
390 Added 1.35%
29,261 $4.74 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $974,927 - $1.23 Million
9,075 Added 45.84%
28,871 $3.91 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $356,440 - $404,613
3,350 Added 20.37%
19,796 $2.14 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $1.73 Million - $1.93 Million
16,446 New
16,446 $1.85 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Bridge Investment Counsel Inc. Portfolio

Follow Wealth Bridge Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Bridge Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Bridge Investment Counsel Inc. with notifications on news.